Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05981300 · ClinicalTrials.gov registry record
GpCRC Pediatric Gastroparesis Registry 2
A clinical trial of Gastroparesis and Gastroparesis-like Syndrome, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- 216
- Enrollment target
- 6
- Study locations
NCT05981300: Recruiting study of Gastroparesis and Gastroparesis-like Syndrome, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT05981300 is a study of Gastroparesis and Gastroparesis-like Syndrome that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 216 participants, below the 297-participant average among 44 other Gastroparesis trials with a reported enrollment target (27% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05981300, a study of Gastroparesis and Gastroparesis-like Syndrome, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- 216 participants
- Enrollment target
- 6
- Study locations
Study Summary
The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).
Primary Outcome
The PedsQL™ GI Symptoms Scales questionnaire has 65 response items covering 10 dimensions, with each item offered as a better-to-worse 5-point Likert scale choice: 0=never, 1=almost never, 2=sometimes, 3=often, 4=almost always. The item responses are transformed to a worse-to-better order and rescaled to 0-100: 0=almost always, 25= often, 50=sometimes, 75=almost never, 100= never, with higher scores indicating better health-related quality of life (HRQOL) and fewer problems or symptoms.he per-pa
Conditions Studied
Study Locations (6)
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
Texas
- Texas Tech University Health Science Center - El Paso
- Baylor College of Medicine/Texas Children's Hospital - Houston
Ohio
- Nationwide Children's Hospital - Columbus
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2024-12-18 |
| Est. Completion | 2027-06-30 |
What NCT05981300 shows while recruiting
NCT05981300 is an observational study that tracks outcomes without assigning an intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 297-participant average among 44 other Gastroparesis trials with a reported enrollment target (27% lower).
The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.
NCT05981300 lists 6 locations in 4 states (Massachusetts, Texas, Ohio).
Frequently Asked Questions
What is clinical trial NCT05981300 about?
NCT05981300 is a clinical study titled "GpCRC Pediatric Gastroparesis Registry 2". The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).
What is the current status of trial NCT05981300?
This trial is currently recruiting. The enrollment target is 216 participants. The study started on 2024-12-18. Estimated completion is 2027-06-30.
What conditions does trial NCT05981300 study?
This clinical trial studies the following conditions: Gastroparesis, Gastroparesis-like Syndrome.
Who is sponsoring clinical trial NCT05981300?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05981300 being conducted?
This trial has 6 study locations across Massachusetts, Ohio, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05981300's enrollment target sits among peer trials
216 11th of 44 higher than 34 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI